Botox won its fourth U.S. Food and Drug Administration approval yesterday, for the treatment of excessive sweating. Injections of the drug into the armpit seem to essentially paralyze the sweat glands; taking shots once or twice a year (at $1,000 to $2,000 a pop) seems to help patients with severe underarm sweating.
Specialty pharmaceutical maker Allergan has been riding the wave of what may turn out to be the first biotech “miracle drug,” with more applications than initially imagined. The protein therapeutic, a low concentration injection of the toxin that causes botulism food poisoning, has already been approved for the treatment of wrinkles and certain muscle spasms in the neck and eye. It is also being studied for the relief of migraines, muscle spasticity in cerebral palsy, muscle tightness in stroke patients, and involuntary movements such as those associated with Parkinson disease.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.